OTC · Conglomerates

Beroni Group Limited (BNIGF) Stock

$0.01 +0.00% OTC: BNIGF Healthcare

Beroni Group Limited, established in 2014 and based in Sydney, Australia, is a global enterprise operating in China, Australia, the United States, and Japan. The company specializes in the creation and distribution of a diverse portfolio of health and wellness products.

Valuation

MetricValue
Price$0.01
Market Cap$212760
P/E Ratio-0.06
P/B Ratio0.06
P/S Ratio0.48
EPS (TTM)$-0.13
52-Week High$0.01
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-76.18%
ROA-53.25%
ROCE-186.17%
Gross Margin75.17%
Operating Margin-500.00%
Net Margin-661.66%
Debt/Equity0.36
Current Ratio1.25

Annual Financials (USD)

Metric20212022202320242025
Revenue$2.0M$1.0M$0$0$1.0M
Operating Profit$-4.0M$-9.0M$-6.0M$-12.0M$-5.0M
Net Profit$-3.0M$-8.0M$-9.0M$-11.0M$-4.0M
EPS$-0.04$-0.42$-0.47$-0.46$-0.13
Op Margin-168.6%-1441.5%-1200.1%-3871.1%-737.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$12.0M$10.0M$10.0M$7.0M$8.0M
Total Liabilities$4.0M$3.0M$10.0M$4.0M$3.0M
Cash$6.0M$3.0M$4.0M$2.0M$0
Borrowings$3.0M$2.0M$5.0M$2.0M$2.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$-2.0M$-3.0M$-3.0M$-2.0M
Investing Cash Flow$0$-2.0M$0$0$0
Financing Cash Flow$0$0$0$1.0M$0
Net Cash Flow$1.0M$-3.0M$1.0M$-2.0M$-1.0M
Free Cash Flow$-2.0M$-3.0M$-3.0M$-3.0M$-2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.38
FCF Yield-779.23%
Quick Ratio1.24
Interest Coverage0.00
Return 1Y0.00%
Return 3Y-99.94%
Return 5Y—

Ownership

Insiders Held73.93%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CIRXCirtran Corp $0.03 +0.00% 0.09 $148363 0.00%
CSLICritical Solutions, Inc. $0.00 — -1.00 $64860 0.00%
DLOCDigital Locations Inc $0.00 — -0.01 $73377 0.00%
DSUSDrone Services USA, Inc. $0.00 — -7.96 $65633 0.00%
ELGLElement Global, Inc. $0.00 — 0.02 $81696 0.00%

About Beroni Group Limited

Beroni Group Limited, established in 2014 and based in Sydney, Australia, is a global enterprise operating in China, Australia, the United States, and Japan. The company specializes in the creation and distribution of a diverse portfolio of health and wellness products. Its offerings span several key areas: Smoking Harm Reduction: This includes products like NicoBloc, designed to aid in smoking cessation. Environmental Quality: Beroni provides air purification systems, such as Fogibloc, and water filtration solutions under the Olansi brand. Health and Wellness: The company supplies a variety of health supplements and also markets cosmetic products, including V show rejuvenation liquids and various hyaluronic acid and avocado-based intensive treatment masks. Stem cell-derived cosmetic products are also part of its range. Diagnostic Tools: Beroni is active in the diagnostics field, offering detection kits for viruses like the SARS-CoV-2 IgG/IgM antibody kit for COVID-19, as well as the CII-ArboViroPlex rRT-PCR assay, which identifies arboviruses such as Zika, Dengue, Chikungunya, and West Nile. Beyond product sales, Beroni Group is heavily invested in research and development. Its R&D efforts focus on discovering and developing novel pharmaceutical drugs, conducting clinical trials, and advancing anti-cancer therapies. The company also provides services in gene detection and diagnosis, infectious disease diagnostics, and offers cell therapies for both cancer treatment and anti-aging applications. Furthermore, Beroni manages an e-commerce platform dedicated to pharmaceutical and healthcare products.

Beroni Group Limited is headquartered in AU.

Beroni Group Limited (BNIGF) stock trades at $0.01 with a market capitalization of $212760. The stock is valued at a price-to-earnings (P/E) ratio of -0.06, price-to-book of 0.06, price-to-sales of 0.48. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades at its 52-week high.

On profitability, Beroni Group Limited generates a return on equity (ROE) of -76.18%, return on capital employed of -186.17%, an operating margin of -500.00%, a net profit margin of -661.66%.

Official website: www.beronigroup.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides